Despite Trump call, experts say total reshoring of American pharma manufacturing unrealistic
Fears of coronavirus second wave prompt flu push at US pharmacies, drugmakers
Roche’s Tecentriq gets a green light to challenge Bayer with first-in-class liver cancer nod
Pfizer’s latest podcast series centers on COVID-19 research and updates